Literature DB >> 2107799

Isotype distribution of anticardiolipin antibodies in systemic lupus erythematosus: prospective analysis of a series of 100 patients.

R Cervera1, J Font, A López-Soto, F Casals, L Pallarés, A Bové, M Ingelmo, A Urbano-Márquez.   

Abstract

A prospective study of IgG and IgM isotypes of anticardiolipin antibodies (aCL) in a series of 100 patients with systemic lupus erythematosus was carried out. To determine the normal range of both isotype titres a group of 100 normal control serum samples was studied and a log-normal distribution of IgG and IgM isotypes was found. The IgG anticardiolipin antibody serum was regarded as positive if a binding index greater than 2.85 (SD 3.77) was detected and a binding index greater than 4.07 (3.90) was defined as positive for IgM anticardiolipin antibody. Twenty four patients were positive for IgG aCL, 20 for IgM aCL, and 36 for IgG or IgM aCL, or both. IgG aCL were found to have a significant association with thrombosis and thrombocytopenia, and IgM aCL with haemolytic anaemia and neutropenia. Specificity and predictive value for these clinical manifestations increased at moderate and high anticardiolipin antibody titres. In addition, a significant association was found between aCL and the presence of lupus anticoagulant. Identification of these differences in the anticardiolipin antibody isotype associations may improve the clinical usefulness of these tests, and this study confirms the good specificity and predictive value of the anticardiolipin antibody titre for these clinical manifestations.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2107799      PMCID: PMC1003989          DOI: 10.1136/ard.49.2.109

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  30 in total

1.  IgG and IgM anticardiolipin antibodies in patients with lupus with anticardiolipin antibody associated clinical syndromes.

Authors:  M E Cronin; R M Biswas; C Van der Straeton; T A Fleisher; J H Klippel
Journal:  J Rheumatol       Date:  1988       Impact factor: 4.666

2.  Occurrence of both hemolytic anemia and thrombocytopenic purpura (Evans' syndrome) in systemic lupus erythematosus. Relationship to antiphospholipid antibodies.

Authors:  M Delezé; C V Oria; D Alarcón-Segovia
Journal:  J Rheumatol       Date:  1988-04       Impact factor: 4.666

3.  Deoxyribonucleic acid antibody: a method to detect its primary interaction with deoxyribonucleic acid.

Authors:  R T Wold; F E Young; E M Tan; R S Farr
Journal:  Science       Date:  1968-08-23       Impact factor: 47.728

4.  Pathogenetic potential of antiphospholipid antibodies.

Authors:  D Alarcón-Segovia
Journal:  J Rheumatol       Date:  1988-06       Impact factor: 4.666

5.  Report of the Working Party on Acquired Inhibitors of Coagulation: studies of the "lupus" anticoagulant.

Authors:  D Green; C Hougie; F J Kazmier; K Lechner; P M Mannucci; C R Rizza; Y Sultan
Journal:  Thromb Haemost       Date:  1983-04-28       Impact factor: 5.249

6.  Antinuclear antibody, lupus anticoagulant, and anticardiolipin antibody in women with idiopathic habitual abortion. A controlled, prospective study of forty-four women.

Authors:  M Petri; M Golbus; R Anderson; Q Whiting-O'Keefe; L Corash; D Hellmann
Journal:  Arthritis Rheum       Date:  1987-06

7.  The 1982 revised criteria for the classification of systemic lupus erythematosus.

Authors:  E M Tan; A S Cohen; J F Fries; A T Masi; D J McShane; N F Rothfield; J G Schaller; N Talal; R J Winchester
Journal:  Arthritis Rheum       Date:  1982-11

8.  Thrombosis in systemic lupus erythematosus: striking association with the presence of circulating lupus anticoagulant.

Authors:  M L Boey; C B Colaco; A E Gharavi; K B Elkon; S Loizou; G R Hughes
Journal:  Br Med J (Clin Res Ed)       Date:  1983-10-08

9.  Thrombosis in patients with the lupus anticoagulant.

Authors:  J R Mueh; K D Herbst; S I Rapaport
Journal:  Ann Intern Med       Date:  1980-02       Impact factor: 25.391

10.  Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus.

Authors:  E N Harris; A E Gharavi; M L Boey; B M Patel; C G Mackworth-Young; S Loizou; G R Hughes
Journal:  Lancet       Date:  1983-11-26       Impact factor: 79.321

View more
  17 in total

1.  Anti-chromatin antibodies in systemic lupus erythematosus: a useful marker for lupus nephropathy.

Authors:  R Cervera; O Viñas; M Ramos-Casals; J Font; M García-Carrasco; A Sisó; F Ramírez; Y Machuca; J Vives; M Ingelmo; R W Burlingame
Journal:  Ann Rheum Dis       Date:  2003-05       Impact factor: 19.103

Review 2.  'Overlap' syndromes.

Authors:  R Cervera; M A Khamashta; G R Hughes
Journal:  Ann Rheum Dis       Date:  1990-11       Impact factor: 19.103

3.  Antiphospholipid antibodies: which and when?

Authors:  R Cervera; J Font; M A Khamashta; G R Hughes
Journal:  Postgrad Med J       Date:  1990-11       Impact factor: 2.401

4.  Cardiac disease in systemic lupus erythematosus: prospective study of 70 patients.

Authors:  R Cervera; J Font; C Paré; M Azqueta; F Pérez-Villa; A López-Soto; M Ingelmo
Journal:  Ann Rheum Dis       Date:  1992-02       Impact factor: 19.103

5.  Reassessing the status of antiphospholipid syndrome in systemic lupus erythematosus.

Authors:  J L Vianna; H J Haga; P Tripathi; R Cervera; M A Khamashta; G R Hughes
Journal:  Ann Rheum Dis       Date:  1992-02       Impact factor: 19.103

Review 6.  Anaemia in systemic lupus erythematosus: from pathophysiology to clinical assessment.

Authors:  S Giannouli; M Voulgarelis; P D Ziakas; A G Tzioufas
Journal:  Ann Rheum Dis       Date:  2005-08-03       Impact factor: 19.103

Review 7.  Pregnancy and systemic lupus erythematosus: review of clinical features and outcome of 51 pregnancies at a single institution.

Authors:  Graziela Carvalheiras; Pedro Vita; Susana Marta; Rita Trovão; Fátima Farinha; Jorge Braga; Guilherme Rocha; Isabel Almeida; António Marinho; Teresa Mendonça; Paulo Barbosa; João Correia; Carlos Vasconcelos
Journal:  Clin Rev Allergy Immunol       Date:  2010-04       Impact factor: 8.667

8.  Systemic lupus erythematosus (SLE) in childhood: analysis of clinical and immunological findings in 34 patients and comparison with SLE characteristics in adults.

Authors:  J Font; R Cervera; G Espinosa; L Pallarés; M Ramos-Casals; S Jiménez; M García-Carrasco; L Seisdedos; M Ingelmo
Journal:  Ann Rheum Dis       Date:  1998-08       Impact factor: 19.103

9.  Systemic lupus erythematosus in the elderly: clinical and immunological characteristics.

Authors:  J Font; L Pallarés; R Cervera; A López-Soto; M Navarro; X Bosch; M Ingelmo
Journal:  Ann Rheum Dis       Date:  1991-10       Impact factor: 19.103

10.  Anticardiolipin antibodies and lupus anticoagulant in patients treated with different methods of renal replacement therapy in comparison to patients with systemic lupus erythematosus.

Authors:  T Sitter; M Spannagl; H Schiffl
Journal:  Ann Hematol       Date:  1992-08       Impact factor: 3.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.